← Leaderboards
Trevor J. Orchard
University Of Pittsburgh At Pittsburgh
$23,296,930
Attributed
$23,296,930
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2005–18$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$23,296,930 · 8
By mechanism
U01$6,897,605 · 1
R01$6,696,149 · 2
R37$6,502,306 · 1
T32$1,922,086 · 1
RC4$1,200,000 · 1
R03$75,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Tina Costacou$2,896,697
Others in their field
Top investigators on “Epidemiology”
- David Heimbrook · Leidos Biomedical Research, Inc.$390,770,069
- George R Seage · Abt Associates, Inc.$299,251,523
- Jeffrey P Krischer · University Of South Florida$264,076,260
- Barbara Driver · Westat, Inc.$221,167,491
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,739,528
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
EpidemiologyDiabetes MellitusCohortRisk FactorsIncidenceFollow-UpAffectDiabetes PreventionComplications Of Diabetes MellitusDiagnosisPrevalenceFundingNon-Insulin-Dependent Diabetes MellitusMorbidity - Disease RateComplicationInsulin ResistanceChildhoodNatural HistoryHealthcareRegistriesResearch PersonnelSurveysInsulinExposure To
Grant awards (49)
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$619,390
R37 · FY2018 · DK · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$673,290
R37 · FY2017 · DK · contact PI
Cardiovascular Epidemiology Training Program$221,480
T32 · FY2017 · HL · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$650,190
R37 · FY2016 · DK · contact PI
Cardiovascular Epidemiology Training Program$362,791
T32 · FY2016 · HL · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$624,124
R37 · FY2015 · DK · contact PI
Cardiovascular Epidemiology Training Program$356,277
T32 · FY2015 · HL · contact PI
Diabetes Prevention Program$701,459
U01 · FY2014 · DK · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$634,995
R37 · FY2014 · DK · contact PI
Cardiovascular Epidemiology Training Program$352,013
T32 · FY2014 · HL · contact PI
Diabetes Prevention Program$769,586
U01 · FY2013 · DK · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$553,655
R37 · FY2013 · DK · contact PI
Cardiovascular Epidemiology Training Program$338,283
T32 · FY2013 · HL · contact PI
Diabetes Prevention Program$764,098
U01 · FY2012 · DK · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$601,756
R37 · FY2012 · DK · contact PI
Cardiovascular Epidemiology Training Program$291,242
T32 · FY2012 · HL · contact PI
Diabetes Prevention Program$692,890
U01 · FY2011 · DK · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$650,335
R37 · FY2011 · DK · contact PI
Health system based clinical trial recruitment$75,750
R03 · FY2011 · DK · contact PI
Evaluation of Differing Type 1 Diabetes Regimens in Youth in the Developing World$1,200,000
RC4 · FY2010 · DK · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$715,074
R37 · FY2010 · DK · contact PI
Diabetes Prevention Program$625,601
U01 · FY2010 · DK · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$46,290
R37 · FY2010 · DK · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$15,810
R37 · FY2010 · DK · contact PI
Epidemiology of Diabetes Complications (EDC) Phase II: renewal$717,397
R37 · FY2009 · DK · contact PI
Diabetes Prevention Program$625,601
U01 · FY2009 · DK · contact PI
Diabetes Prevention Program$620,533
U01 · FY2008 · DK · contact PI
Epidemiology of Diabetes Complication:Phase II$504,506
R01 · FY2008 · DK · contact PI
Epidemiology of Diabetes Complication:Phase II$530,361
R01 · FY2007 · DK · contact PI
Diabetes Prevention Program$349,535
U01 · FY2007 · DK · contact PI
Progression of Cardiovascular Disease in TID: CADRE/EDC$235,313
R01 · FY2007 · DK · contact PI
Epidemiology of Diabetes Complication:Phase II$5,000
R01 · FY2007 · DK · contact PI
Epidemiology of Diabetes Complication:Phase II$557,329
R01 · FY2006 · DK · contact PI
Diabetes Prevention Program$507,919
U01 · FY2006 · DK · contact PI
Progression of Cardiovascular Disease in TID: CADRE/EDC$442,391
R01 · FY2006 · DK · contact PI
Epidemiology of Diabetes Complication:Phase II$630,346
R01 · FY2005 · DK
Progression of Cardiovascular Disease in TID: CADRE/EDC$523,742
R01 · FY2005 · DK
Diabetes Prevention Program$501,393
U01 · FY2005 · DK
Epidemiology of Diabetes Complication:Phase II$668,912
R01 · FY2004 · DK
Progression of Cardiovascular Disease in TID: CADRE/EDC$380,285
R01 · FY2004 · DK
Diabetes Prevention Program$356,219
U01 · FY2004 · DK
Diabetes Prevention Program$382,771
U01 · FY2003 · DK
EPIDEMIOLOGY OF DIABETIC COMPLICATIONS--PHASE II$240,325
R01 · FY2003 · DK
EPIDEMIOLOGY OF DIABETIC COMPLICATIONS--PHASE II$112,565
R01 · FY2003 · DK
EPIDEMIOLOGY OF DIABETIC COMPLICATIONS--PHASE II$493,150
R01 · FY2002 · DK
EPIDEMIOLOGY OF DIABETIC COMPLICATIONS--PHASE II$109,329
R01 · FY2002 · DK
EPIDEMIOLOGY OF DIABETIC COMPLICATIONS--PHASE II$586,400
R01 · FY2001 · DK
EPIDEMIOLOGY OF DIABETIC COMPLICATIONS--PHASE II$676,195
R01 · FY2000 · DK
PLACEBO CONTROLLED SAFETY/EFFICACY STUDY OF AMINOGUANIDINE IN DIABETIC PATIENTS$3,034
M01 · FY2000 · RR